<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://onwar.se/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="https://onwar.se/feed.php">
        <title>Onwards - translational_models</title>
        <description></description>
        <link>https://onwar.se/</link>
        <image rdf:resource="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg" />
       <dc:date>2026-09-26T03:21:44+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="https://onwar.se/doku.php?id=translational_models:evaluating_glow_in_preclinical_trials&amp;rev=1790356206&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg">
        <title>Onwards</title>
        <link>https://onwar.se/</link>
        <url>https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg</url>
    </image>
    <item rdf:about="https://onwar.se/doku.php?id=translational_models:evaluating_glow_in_preclinical_trials&amp;rev=1790356206&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-09-25T17:10:06+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>evaluating_glow_in_preclinical_trials</title>
        <link>https://onwar.se/doku.php?id=translational_models:evaluating_glow_in_preclinical_trials&amp;rev=1790356206&amp;do=diff</link>
        <description>The biomedical research world changes constantly, pushed forward by novel compounds, peptides, and signaling molecules holding promise for therapy. Among these, the compound referenced in specialized scientific circles as GLOW has drawn intense focus. As scientists move from initial lab bench findings to complex biological setups, translational models step in. Evaluating GLOW in preclinical trials bridges basic pharmacology and actual clinical use, showing clear views on pharmacokinetics, pharma…</description>
    </item>
</rdf:RDF>
